MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
WIPO _ Which are the most innovative economies in 2026?
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Massachusetts
*Triple Helix Cluster & Developments: Massachusetts
*Industry: Massachusetts
Dyne Therapeutics, Inc. (Nasdaq: DYN)*
Organization & Developments: Dyne Therapeutics
Parents
Dyne Therapeutics, Inc. (Nasdaq: DYN)*
Children
*Dyne is developing treatments for rare, inherited muscle disorders.
*Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases
2022: Dyne Therapeutics Receives FDA Fast Track Designation for
2024: Assessing Dyne Therapeutics' Muscular Dystrophy Data: Early Promise, Caution Needed_ seekingalpha.com
2024: Dyne Therapeutics: An Updated Analysis
2024: Dyne Therapeutics' DMD Drug Shows Promise; $723.7M Cash Position Fuels Clinical Progress
2024: Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases
2024: Dyne: H2 2024 Muscle Disease Data Could Boost Value
2024: Dyne: H2 2024 Muscle Disease Data Could Boost Value
2025: Dyne Therapeutics: Moving Forward On 2 Key Fronts
2025: Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
2025: Dyne: Accelerated Approval Of DYNE-101 Might Be Possible With Surrogate Biomarker_ seekingalpha.com
2025: Neuromuscular Disease Breakthroughs: Dyne Therapeutics Reveals Latest Progress at CNS Forum
Jumps
Finance & Acquisitions: Dyne Therapeutics
Key People: Dyne Therapeutics